Profile: Aldagen, Inc develops proprietary regenerative cell therapies. Our products include ALD-101, ALD-301 and ALD-201. Our ALD-101 is designed to improve the umbilical cord blood transplants that are used to treat inherited metabolic diseases in pediatric patients. We conduct clinical trial of ALD-301 in treating critical limb ischemia and it provides ALD-201 for the treatment of ischemic heart failure. We also focus on isolating adult stem cells that express ALDH, consists products to improve cord blood transplants. This is offered to treat leukemias, for the treatment of inherited metabolic diseases and for the post-acute treatment of ischemic strokes.
2 Products/Services (Click for related suppliers)
|
• Differential Cell Counter (FDA Code: GKZ / 864.5220) An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers. |
• Pharmaceuticals |